Proteostasis Therapeutics, Inc.

117 articles about Proteostasis Therapeutics, Inc.

• Proteostasis Announces Closing Of Follow-On Public Offering Of Common Stock

  9/15/2016

• Proteostasis Announces Pricing Of Public Offering Of Common Stock

  9/9/2016

• Proteostasis Achieves Preclinical Milestone In Astellas Collaboration

  8/9/2016

• Proteostasis Announces Key Leadership Appointments

  8/8/2016

• Proteostasis Presents New Data Demonstrating Potential For Genotype-Agnostic And Combination Therapies For People With Cystic Fibrosis

  4/1/2016

• Proteostasis Debuts Well-Below Expected Range But Still Raises $50 Millon in IPO

  2/11/2016

• Proteostasis Files for a $86 Million IPO

  12/29/2015

• Proteostasis Therapeutics, Inc. Announces Management Changes To Strengthen Research And Development Organization

  12/11/2015

• Proteostasis Therapeutics, Inc. Demonstrates Therapeutic Potential Of A Proprietary Triple Combination Therapy For The Treatment Of Cystic Fibrosis That Restores Activity Of Mutant F508del CFTR Protein To 80% Of Normal

  11/23/2015

• Proteostasis Therapeutics, Inc. Presents Preclinical Data For Its CFTR Amplifier Program At The 29th Annual North American Cystic Fibrosis Conference

  10/12/2015

• Proteostasis Therapeutics, Inc. Raises $37 Million In Crossover Financing

  9/8/2015

• Proteostasis Therapeutics, Inc. Announces A New Class Of Agents For Cystic Fibrosis Called CFTR Amplifiers And Selects PTI130 As A Development Candidate

  2/5/2015

• Proteostasis Therapeutics, Inc. Announces Appointment Of Dr. Po-Shun Lee As Vice President Of Clinical Development

  12/3/2014

• Proteostasis Therapeutics, Inc. Announces Scientific Publication In Cell Reports

  11/6/2014

• Astellas, Proteostasis Forge $1.2 Billion Genetic Disease Drug Pact

  11/5/2014

• Proteostasis Therapeutics, Inc. Announces Appointments Of Cystic Fibrosis Experts To Inaugural Clinical Advisory Board

  10/20/2014

• Proteostasis Therapeutics, Inc. Announces Achievement Of Preclinical Milestone In Neurodegenerative Diseases Collaboration With Biogen Idec, Inc. (Massachusetts)

  7/30/2014

• Proteostasis Therapeutics, Inc. Brings In Meenu Chhabra As CEO

  6/30/2014

• Proteostasis Therapeutics, Inc. Announces Extension Of Funded Collaboration With Cystic Fibrosis Foundation Therapeutics, Inc. For Novel Therapies Targeting Most Common CF Mutation

  3/4/2014

• Biogen Idec, Inc. (Massachusetts), Proteostasis Therapeutics, Inc. Hammer Out $200 Million+ Pre-Clinical Alzheimer's Pact

  12/9/2013